Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hot Flashes 6Breast Neoplasms 6Pain, Postoperative 3Head and Neck Neoplasms 3Vomiting 2Prostatic Neoplasms 2Pain 2Nausea 2Mucositis 2Depression 2Anxiety Disorders 2Acute Pain 2Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neuralgia 1Neoplasms 1Laryngeal Diseases 1Agnosia 1Abnormalities, Radiation-Induced 1

Interventions

Paclitaxel 5Vincristine 3Oxaliplatin 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Carboplatin 3Amifostine 3xaliproden 2glucarpidase 2Taxes 2Radiotherapy 2Psychiatric Rehabilitation 2Procarbazine 2Methotrexate 2Magnesium Sulfate 2Leucovorin 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2Calcium Gluconate 22,2'-dithiodiethanesulfonic acid 2neurotropin 1glutamic acid diethyl ester 1eribulin 1axicabtagene ciloleucel 1Vitamin E 1Trastuzumab 1Thioctic Acid 1Thalidomide 1Tadalafil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurotoxicity Syndromes × Gabapentin × Clear all
NCT00027963 2016-07-04

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
100 enrolled

Pain, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡